Vacunación de COVID-19 en grupos ginecológicos y obstétricos especiales

María Antonia Buenaventura Rubio
{"title":"Vacunación de COVID-19 en grupos ginecológicos y obstétricos especiales","authors":"María Antonia Buenaventura Rubio","doi":"10.19230/JONNPR.4187","DOIUrl":null,"url":null,"abstract":"espanolLa pandemia por COVID-19 y las serias repercusiones que esta teniendo han hecho que se agilice el desarrollo de un arma terapeutica fundamental para comenzar a erradicarla: las vacunas. Son un instrumento fundamental de prevencion primaria que se administrara inicialmente a los grupos mas vulnerables o con alto riesgo de exposicion, ampliando el abanico de administracion a otro tipo de poblacion en fases posteriores. Puede surgir controversia a la hora de vacunar a grupos ginecologicos especificos, como son las gestantes, mujeres lactantes o pacientes con cancer ginecologico. El proposito de este articulo es analizar la informacion disponible con respecto a la vacunacion en estos grupos. EnglishThe COVID-19 pandemic and its serious repercussions are accelerating the development of a fundamental therapeutic strategy to begin eradicating this illness: vaccines. They are a fundamental instrument of primary prevention that will be administer initially to vulnerable groups or those with high risk of exposure, expanding in later phases the administration to another populations. There can be controversy in vaccinating some specific gynecological groups, like pregnant women, lactating women or patients with gynecological cancer. The purpose of this article is to analyze the information available regarding vaccination in these concrete groups.","PeriodicalId":265734,"journal":{"name":"Jounal of Negative and No Positive Results","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jounal of Negative and No Positive Results","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19230/JONNPR.4187","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

espanolLa pandemia por COVID-19 y las serias repercusiones que esta teniendo han hecho que se agilice el desarrollo de un arma terapeutica fundamental para comenzar a erradicarla: las vacunas. Son un instrumento fundamental de prevencion primaria que se administrara inicialmente a los grupos mas vulnerables o con alto riesgo de exposicion, ampliando el abanico de administracion a otro tipo de poblacion en fases posteriores. Puede surgir controversia a la hora de vacunar a grupos ginecologicos especificos, como son las gestantes, mujeres lactantes o pacientes con cancer ginecologico. El proposito de este articulo es analizar la informacion disponible con respecto a la vacunacion en estos grupos. EnglishThe COVID-19 pandemic and its serious repercussions are accelerating the development of a fundamental therapeutic strategy to begin eradicating this illness: vaccines. They are a fundamental instrument of primary prevention that will be administer initially to vulnerable groups or those with high risk of exposure, expanding in later phases the administration to another populations. There can be controversy in vaccinating some specific gynecological groups, like pregnant women, lactating women or patients with gynecological cancer. The purpose of this article is to analyze the information available regarding vaccination in these concrete groups.
特殊妇科和产科群体的COVID-19疫苗接种
西班牙COVID-19大流行及其严重影响加快了一种基本治疗武器的开发,以开始根除它:疫苗。它们是初级预防的基本工具,最初将对最脆弱或接触风险较高的群体实施,并在后期将实施范围扩大到其他类型的人群。在为特定的妇科群体(如孕妇、哺乳期妇女或妇科癌症患者)接种疫苗时可能会出现争议。然而,在这些群体中,疫苗接种是最常见的。COVID-19大流行及其严重影响正在加速制定一项基本治疗战略,开始根除这一疾病:疫苗。它们是初级预防的一项基本工具,最初将针对易受伤害群体或暴露风险高的群体进行管理,在后期阶段将管理范围扩大到其他人群。对于某些特定的妇科群体,如孕妇、哺乳期妇女或妇科癌症患者,接种疫苗可能存在争议。本文的目的是分析这些特定群体中有关疫苗接种的现有信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信